hOMSC300

· Cytora Ltd.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for hOMSC300, covering 2025-01-29 to 2025-01-29. Get the full timeline:

Most recent: Clinical Trial Update: Study to Evaluate Investigational Allogeneic Cell Therapy Product hOMSC300 for Treatment of Early to Moderate Stage Multiple System Atrophy (MSA) [Phase 1]

See pricing